Home > Insider Trading > Filing (0001209191-18-064123)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1649989	Outlook Therapeutics Inc.	OTLK	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1191504	J Kurt Hilzinger	C/O Outlook Therapeutics, Inc. 7 Clarke Drive Cranbury NJ 08512		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-12-21	3,600	$0.65	41,400	No	4	P	Direct
Common Stock	Acquisiton	2018-12-24	1,113	$0.66	42,513	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.63 - $0.6706, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
Includes an aggregate of 7,246 shares that were issued upon vesting and settlement of Restricted Stock Units previously reported in a Form 3 filed with the Securities and Exchange Commission on May 12, 2016 but erroneously omitted from Column 5 in subsequent filings.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.65 - $0.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.